Terms: = Thyroid cancer AND CCND1, BCL1, 595, ENSG00000110092, PRAD1, U21B31, D11S287E AND Treatment
28 results:
1. Development and validation of prediction models for papillary thyroid cancer structural recurrence using machine learning approaches.
Wang H; Zhang C; Li Q; Tian T; Huang R; Qiu J; Tian R
BMC Cancer; 2024 Apr; 24(1):427. PubMed ID: 38589799
[TBL] [Abstract] [Full Text] [Related]
2. Survival trends and patient characteristics between 2004 and 2016 for breast cancer in Japan based on the National Clinical Database-Breast cancer Registry.
Iwamoto T; Kumamaru H; Niikura N; Sagara Y; Miyashita M; Konishi T; Sanuki N; Tanakura K; Nagahashi M; Hayashi N; Yoshida M; Watanabe C; Kinukawa N; Toi M; Saji S
Breast Cancer; 2024 Mar; 31(2):185-194. PubMed ID: 38319565
[TBL] [Abstract] [Full Text] [Related]
3. [Diagnostic Value of American thyroid Association Guidelines,American College of Radiology thyroid Imaging Reporting and Data System,and Chinese thyroid Imaging Reporting and Data System Alone and Combined With BRAF
Lin Y; Luo YK; Li J; Ren XY; Wang HW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Dec; 45(6):921-928. PubMed ID: 38173102
[TBL] [Abstract] [Full Text] [Related]
4. Incidence of Endocrine-Related Dysfunction in Patients Treated with New Immune Checkpoint Inhibitors: A Meta-Analysis and Comprehensive Review.
Yoo WS; Ku EJ; Lee EK; Ahn HY
Endocrinol Metab (Seoul); 2023 Dec; 38(6):750-759. PubMed ID: 37956967
[TBL] [Abstract] [Full Text] [Related]
5. Network Pharmacological Analysis and Experimental Validation of the Effects of Silybin on Proliferation, Migration, and Immunotherapy of Papillary thyroid cancer.
Xie W; Li H; Lin Q; Ke N
Endocr Metab Immune Disord Drug Targets; 2024; 24(6):672-690. PubMed ID: 37855349
[TBL] [Abstract] [Full Text] [Related]
6. ccnd1-associated ceRNA network reveal the critical pathway of TPRG1-AS1-hsa-miR-363-3p-MYO1B as a prognostic marker for head and neck squamous cell carcinoma.
Li Z; Qiu X; He Q; Fu X; Ji F; Tian X
Sci Rep; 2023 Jul; 13(1):11831. PubMed ID: 37481637
[TBL] [Abstract] [Full Text] [Related]
7. Identification of BRAF, ccnd1, and MYC mutations in a patient with multiple primary malignant tumors: a case report and review of the literature.
Liu Z; Jin C; Zhang Y; Jiang Y; Wang J; Zheng L
World J Surg Oncol; 2023 May; 21(1):158. PubMed ID: 37221610
[TBL] [Abstract] [Full Text] [Related]
8. A prospective study to evaluate the treatment effect of pulsed dye laser on thyroidectomy hypertrophic scars using 3D imaging analysis.
Kim JC; Choi JW; Kim YC
Lasers Surg Med; 2022 Oct; 54(8):1082-1088. PubMed ID: 35842822
[TBL] [Abstract] [Full Text] [Related]
9. Young non-smokers with oral cancer: What are we missing and why?
Valero C; Yuan A; Zanoni DK; Lei E; Dogan S; Shah JP; Morris LGT; Wong RJ; Mizrachi A; Patel SG; Ganly I
Oral Oncol; 2022 Apr; 127():105803. PubMed ID: 35259623
[TBL] [Abstract] [Full Text] [Related]
10. Clinical impact of radioactive iodine dose selection based on the number of metastatic lymph nodes in patients with papillary thyroid carcinoma: A multicenter retrospective cohort study.
Kwon SY; Kim MH; Kong E; Chong A; Yoo SW; Jeon S; Park SA; Kim DW; Kang SH; Choi JE; Ha JM; Jeong SY; Lee SW
Clin Endocrinol (Oxf); 2021 Dec; 95(6):901-908. PubMed ID: 34185324
[TBL] [Abstract] [Full Text] [Related]
11. HDAC8-dependent deacetylation of PKM2 directs nuclear localization and glycolysis to promote proliferation in hepatocellular carcinoma.
Zhang R; Shen M; Wu C; Chen Y; Lu J; Li J; Zhao L; Meng H; Zhou X; Huang G; Zhao X; Liu J
Cell Death Dis; 2020 Dec; 11(12):1036. PubMed ID: 33279948
[TBL] [Abstract] [Full Text] [Related]
12. Downregulation of lncRNA ZFAS1 inhibits the hallmarks of thyroid carcinoma via the regulation of miR‑302‑3p on cyclin D1.
Chen W; Zhai L; Liu H; Li Y; Zhang Q; Xu D; Fan W
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179076
[TBL] [Abstract] [Full Text] [Related]
13. The Transareola Endoscopic Approach Yields Adequate Oncological Dissection as Open Approach in the treatment of Papillary thyroid Carcinoma.
Gao H; Chen C; Liu X; Xu N; Wang Y; Qu R; Yu X
Surg Laparosc Endosc Percutan Tech; 2019 Dec; 29(6):489-492. PubMed ID: 31584497
[TBL] [Abstract] [Full Text] [Related]
14. Activation of AMPK by metformin promotes renal cancer cell proliferation under glucose deprivation through its interaction with PKM2.
Liu M; Zhang Z; Wang H; Chen X; Jin C
Int J Biol Sci; 2019; 15(3):617-627. PubMed ID: 30745848
[TBL] [Abstract] [Full Text] [Related]
15. Detection at Public Facilities of
Bikas A; Wu D; Bethancourt E; Orquiza M; Bloom G; Burman KD; Wartofsky L; Van Nostrand D
J Nucl Med; 2019 May; 60(5):638-643. PubMed ID: 30361377
[TBL] [Abstract] [Full Text] [Related]
16. Overexpression of Pyruvate Kinase Type M2 (PKM2) Promotes Ovarian cancer Cell Growth and Survival Via Regulation of Cell Cycle Progression Related with Upregulated ccnd1 and Downregulated CDKN1A Expression.
Zheng B; Liu F; Zeng L; Geng L; Ouyang X; Wang K; Huang Q
Med Sci Monit; 2018 May; 24():3103-3112. PubMed ID: 29752805
[TBL] [Abstract] [Full Text] [Related]
17. Simvastatin Inhibits Cell Proliferation and Migration in Human Anaplastic thyroid cancer.
Chen MC; Tsai YC; Tseng JH; Liou JJ; Horng S; Wen HC; Fan YC; Zhong WB; Hsu SP
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29236027
[TBL] [Abstract] [Full Text] [Related]
18. Clinicopathological Significance and Prognosis of Medullary thyroid Microcarcinoma: A Meta-analysis.
Kim JH; Pyo JS; Cho WJ
World J Surg; 2017 Oct; 41(10):2551-2558. PubMed ID: 28451761
[TBL] [Abstract] [Full Text] [Related]
19. Role of microRNAs in endocrine cancer metastasis.
Lima CR; Gomes CC; Santos MF
Mol Cell Endocrinol; 2017 Nov; 456():62-75. PubMed ID: 28322989
[TBL] [Abstract] [Full Text] [Related]
20. Long-Term Follow-Up and treatment of Postoperative Permanent Hypoparathyroidism in Patients with Medullary thyroid Carcinoma: Differences in Complete and Partial Disease.
Leidig-Bruckner G; Bruckner T; Raue F; Frank-Raue K
Horm Metab Res; 2016 Dec; 48(12):806-813. PubMed ID: 27813050
[TBL] [Abstract] [Full Text] [Related]
[Next]
